Close
ACHEMA MIDDLE EAST 2026

Australia Biomedical Space Drives World Innovation, Research

It is worth noting that the new Australian Institute for Infectious Diseases- AIID has been established so as to bring together some of the...

Titan Krios G4 – A Biomed Research Advancement In Australia

In May 2024, the Ramaciotti Centre for Cryo-Electron Microscopy went on to launch the Titan Krios G4 microscope, a state-of-the-art instrument that happens to...

Parenteral Drug Administration – Shaping Today, Tomorrow

Parenteral drug administration has gone on to witness quite a significant set of advancements as well as transformations in recent years. This very crucial method...

Moderna – Respiratory Syncytial Virus Jab Nod Post Spikevax

Moderna has gone on to announce in May 2023 that the US FDA has gone on to approve its respiratory syncytial virus- RSV vaccine,...

Huge Investment In Indiana For Tirzepatide API Production

It is well to be noted that a fresh $5.3 billion investment for pharma giant Eli Lilly and Company’s manufacturing site based in Lebanon,...

Germany – A Strong Force For Pharmaceutical Drug Reshoring

As part of its endeavors to throttle the pharma sector domestically, the German government has gone ahead with the adoption of a strategy paper...

Pharma Solvents Industry Eyeing A $6bn Valuation By 2033

The pharmaceutical solvents sector has gone on to secure a valuation worth $3.9 billion in 2023 and is all set to scale the $6...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...